Ellen A Garber

This inventor holds 35 USPTO granted patents and 17 published patent applications, plus 8 CIPO patents and 10 EPO patents, primarily in Binding Proteins. Top assignees: Biogen Idec Ma Inc., Biogen Ma Inc., Curis, Inc.. Active years: 2002-2017.

USPTO Granted Patents = 35 (Patent Applications = 17)

% Patents Active = 68.6

CIPO Patents = 8 (Patent Applications = 1)

EPO Patents = 10 (Patent Applications = 21)

Average Co-Inventor Count = 4.4

ph-index = 11

Forward Citations = 406(Granted Patents)

Location History:

Cambrdige, MA (US) (2002)
Cambridge, MA (US) (2005 - 2017)

Company Filing History:

Biogen International Neuroscience Gmbh

8. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2017

Loading Chart...

Areas of Expertise:

Binding Proteins

Antibodies

Fc Regions

Nogo Receptor Antagonists

Monocyte Chemotactic Proteins

Tumor Volume Reduction

Hedgehog Activity

Humanized Antibodies

Nucleic Acids

Receptor Coupling Agents

Effector Function

Sp35 Antibodies

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9738707 - Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto (2017-08-22),

2. 9598484 - Human anti-tau antibodies (2017-03-21),

3. 9321840 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof (2016-04-26),

4. 9228015 - Nogo receptor antagonists and methods of increasing neurite outgrowth (2016-01-05),

5. 9096665 - Antibodies against monocyte chemotactic proteins (2015-08-04),

6. 8784823 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof (2014-07-22),

7. 8669345 - Nogo receptor antagonists (2014-03-11),

8. 8618252 - Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto (2013-12-31),

9. 8609407 - Sp35 antibodies and uses thereof (2013-12-17),

10. 8519112 - Humanized antibodies against monocyte chemotactic proteins (2013-08-27),

11. 8431125 - Methods of treating lupus nephritis using antibodies against monocyte chemotactic proteins (2013-04-30),

12. 8410061 - Functional antagonists of hedgehog activity (2013-04-02),

13. 8318917 - Nucleic acids encoding antibodies having altered effector function and methods for making the same (2012-11-27),

14. 8293237 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof (2012-10-23),

15. 8147829 - Anti-IGR-1R antibodies and uses thereof (2012-04-03),

Title: The Innovative Journey of Ellen A. Garber

Introduction: Ellen A. Garber, a pioneering inventor based in Cambridge, MA, has made significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Ellen A. Garber holds several patents in various technological domains, including artificial intelligence, renewable energy, and healthcare devices.

Career Highlights: With a career spanning over two decades, Ellen A. Garber has established herself as a leading figure in the innovation landscape. Her work has been recognized for its creativity and practicality, earning her numerous accolades.

Collaborations: Ellen A. Garber has collaborated with top research institutions, universities, and tech companies to further develop and implement her inventions. Her collaborative spirit has led to the successful commercialization of several groundbreaking technologies.

Conclusion: Ellen A. Garber's relentless pursuit of innovation and her passion for creating solutions to real-world problems have solidified her position as a trailblazer in the world of inventors. Her work continues to inspire future generations of innovators.